Saturday, September 30, 2017 10:01:34 AM
I feel your pain for now, but I'm hoping that the APYP selling of shares will cease and that the management team will get things turned around for the better. I'm trusting that these guys will have some kind of a plan to move forward in a big way. The Outstanding Shares (OS) is still pretty good.
I'm trusting that since the CEO of APYP is Douglas O. McKinnon who is also the Chief Compliance Officer (CCO) of CHRO and was very instrumental for CHRO moving from the .000s to .05 per share... I believe he is not here to tarnish his name and reputation.
Both APYP and CHRO are fully reporting companies that files audited financials with the SEC:
APYP Profile:
https://www.otcmarkets.com/stock/APYP/profile
CHRO Profile:
https://www.otcmarkets.com/stock/CHRO/profile
v/r
Sterling
Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
Recent APYP News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/26/2024 04:13:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/14/2024 02:29:42 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/08/2024 08:13:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/16/2023 05:24:36 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/13/2023 11:29:06 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:43:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 12:53:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/28/2023 08:47:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/28/2023 08:46:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:05:20 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM